US Patent 11174246 Direct AMPK activators
Patent 11174246 was granted and assigned to Rigel Pharmaceuticals on November, 2021 by the United States Patent and Trademark Office.
All edits
Edits on 12 Dec, 2023
Golden AI
Edits made to:
Article (+170 characters)
Article
Patent abstract
Disclosed are benzimidazole compounds, as well as pharmaceutical compositions and methods of use thereof. One embodiment is a compound having the structure
Edits on 18 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 28 Apr, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
111742460
Date of Patent
November 16, 2021
0Patent Application Number
156778090
Date Filed
August 15, 2017
0Official Website
Patent Primary Examiner
Edits on 23 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
111742460
Date of Patent
November 16, 2021
0Patent Application Number
156778090
Date Filed
August 15, 2017
0Official Website
Patent Primary Examiner
Edits on 8 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 18 Nov, 2021
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 11174246 Direct AMPK activators
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
11174246
Date of patent
November 16, 2021
Patent application number
15677809
Date Filed
August 15, 2017
Patent primary examiner
Find more entities like US Patent 11174246 Direct AMPK activators
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
